Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × OTHER × Nevus, Sebaceous of Jadassohn × Clear all

Phase

Phase EARLY_PHASE1 1 Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 179 Neoplasms 117 Polycystic Ovary Syndrome 98 Colorectal Neoplasms 73 Carcinoma, Hepatocellular 72 Prostatic Neoplasms 66 Stomach Neoplasms 51 Precursor Cell Lymphoblastic Leukemia-Lymphoma 45 Lung Neoplasms 45 Pain, Postoperative 39 Pancreatic Neoplasms 38 Carcinoma, Non-Small-Cell Lung 38 Pain 34 Liver Neoplasms 33 Head and Neck Neoplasms 33 Leukemia, Myeloid, Acute 31 Leiomyoma 30 Keratosis, Actinic 29 Recurrence 27 Colonic Neoplasms 27 Brain Neoplasms 26 Neoplasm Metastasis 25 Multiple Myeloma 25 Infertility 25 Uterine Cervical Neoplasms 23 Lymphoma 23 Esophageal Neoplasms 22 Urinary Bladder Neoplasms 21 Papillomavirus Infections 21 Ovarian Neoplasms 21

Interventions

burosumab 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04320316 2022-10-07

ENS

University of Alabama at Birmingham

Phase 4 Completed

1 enrolled 10 charts

Nevus, Sebaceous of Jadassohn

Data powered by HemOnc (CC BY 4.0) Colophon ⚡